- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Strong Balance Sheet with Growth Potential
Global Pharmaceuticals & Biotech Strong Balance Sheet with Growth Potential
Results
14
1 new
Stocks with plenty of capacity to fund future growth
14 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
INCY | US$72.11 | 2.4% | 19.0% | US$14.0b | US$78.26 | PE427.9x | E22.3% | n/a | ||
NBIX | US$120.69 | 4.9% | -10.1% | US$12.0b | US$166.45 | PE35.3x | E27.2% | n/a | ||
EXEL | US$36.85 | 5.3% | 71.2% | US$10.3b | US$36.89 | PE19.8x | E21.3% | n/a | ||
TECH | US$64.92 | -1.5% | -9.4% | US$10.3b | US$85.42 | PE64.9x | E21.9% | 0.5% | ||
CORT | US$63.54 | -12.6% | 183.0% | US$6.7b | US$97.00 | PE47.4x | E38.3% | n/a | ||
KRYS | US$187.86 | 22.6% | 68.7% | US$5.4b | US$211.44 | PE60.7x | E31.7% | n/a | ||
ADMA | US$15.84 | -0.4% | 201.1% | US$3.7b | US$24.27 | PE55x | E26.7% | n/a | ||
ACAD | US$19.95 | -0.4% | -19.5% | US$3.3b | US$24.80 | PE25.8x | E25.3% | n/a | ||
VCEL | US$52.00 | -8.9% | 9.9% | US$2.6b | US$66.50 | PE723.4x | E42.8% | n/a | ||
LGND | US$120.67 | 0.6% | 59.0% | US$2.3b | US$144.00 | PE50.4x | E26.9% | n/a | ||
HRMY | US$34.56 | -11.3% | 6.3% | US$2.0b | US$52.11 | PE16.1x | E28.1% | n/a | ||
DVAX New | US$13.33 | 4.0% | 4.5% | US$1.7b | US$24.75 | PE60.6x | E32.0% | n/a | ||
CDXC | US$5.42 | -7.7% | 256.6% | US$414.9m | US$7.96 | PE279.4x | E81.8% | n/a | ||
BSEM | US$13.80 | -10.5% | 59.5% | US$229.8m | US$32.50 | PE14.5x | E33.8% | n/a |
Page 1 of 1